New arthritis drug copy tested in 300 healthy volunteers
NCT ID NCT06929039
First seen Apr 12, 2026 · Last updated May 17, 2026 · Updated 5 times
Summary
This study tested a new injectable drug called KSHB002, which is a copy of the arthritis medicine Orencia (abatacept). The goal was to see if the new version works the same way in the body, is safe, and causes a similar immune response. Three hundred healthy adults received a single dose of either the new drug or the approved version. The results will help decide if the new drug can be used in future studies for people with rheumatoid arthritis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cliantha Research
Toronto, Ontario, L4W 1A4, Canada
Conditions
Explore the condition pages connected to this study.